ciglitazone has been researched along with glyceryl 2-arachidonate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaminski, NE; Rockwell, CE; Snider, NT; Thompson, JT; Vanden Heuvel, JP | 1 |
1 other study(ies) available for ciglitazone and glyceryl 2-arachidonate
| Article | Year |
|---|---|
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Arachidonic Acids; Benzamides; Cells, Cultured; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Gene Expression; Glycerides; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Jurkat Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; NFATC Transcription Factors; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Prostaglandin D2; Protein Binding; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Response Elements; T-Lymphocytes; Thiazolidinediones | 2006 |